These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7979272)

  • 21. A new triazole, voriconazole (UK-109,496), blocks sterol biosynthesis in Candida albicans and Candida krusei.
    Sanati H; Belanger P; Fratti R; Ghannoum M
    Antimicrob Agents Chemother; 1997 Nov; 41(11):2492-6. PubMed ID: 9371355
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antifungal susceptibility testing of Candida albicans by flow cytometry.
    Gökahmetoglu S; Nedret Koç A; Patiroglu T
    Mycoses; 2003 Sep; 46(8):307-11. PubMed ID: 12950899
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of cytokines and fluconazole on the activity of human monocytes against Candida albicans.
    Baltch AL; Smith RP; Franke MA; Ritz WJ; Michelsen PB; Bopp LH
    Antimicrob Agents Chemother; 2001 Jan; 45(1):96-104. PubMed ID: 11120951
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation between adhesion, enzyme production, and susceptibility to fluconazole in Candida albicans obtained from denture wearers.
    Lyon JP; de Resende MA
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Nov; 102(5):632-8. PubMed ID: 17052640
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action.
    Yeaman MR; Bayer AS; Koo SP; Foss W; Sullam PM
    J Clin Invest; 1998 Jan; 101(1):178-87. PubMed ID: 9421480
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro activity of fluconazole on Candida albicans.
    Abecia LC; Arévalo JM; López MJ
    Microbiologia; 1996 Dec; 12(4):613-20. PubMed ID: 9018696
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fungicidal efficacy of various honeys against fluconazole-resistant Candida species isolated from HIV
    Shokri H; Sharifzadeh A
    J Mycol Med; 2017 Jun; 27(2):159-165. PubMed ID: 28159362
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Susceptibilities of Cryptococcus neoformans strains to platelet binding in vivo and to the fungicidal activity of thrombin-induced platelet microbicidal proteins in vitro.
    Nail S; Robert R; Dromer F; Marot-Leblond A; Senet JM
    Infect Immun; 2001 Feb; 69(2):1221-5. PubMed ID: 11160027
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Purification and in vitro activities of rabbit platelet microbicidal proteins.
    Yeaman MR; Tang YQ; Shen AJ; Bayer AS; Selsted ME
    Infect Immun; 1997 Mar; 65(3):1023-31. PubMed ID: 9038312
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of 2-cyclohexylidenhydrazo-4-phenyl-thiazole compared with those of amphotericin B and fluconazole against clinical isolates of Candida spp. and fluconazole-resistant Candida albicans.
    De Logu A; Saddi M; Cardia MC; Borgna R; Sanna C; Saddi B; Maccioni E
    J Antimicrob Chemother; 2005 May; 55(5):692-8. PubMed ID: 15772140
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of limited exposure to antifungal agents on the germ tube formation of oral Candida albicans.
    Ellepola AN; Samaranayake LP
    J Oral Pathol Med; 1998 May; 27(5):213-9. PubMed ID: 9682984
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virulence factors of fluconazole-susceptible and fluconazole-resistant Candida albicans after antimicrobial photodynamic therapy.
    Alves F; de Oliveira Mima EG; Passador RCP; Bagnato VS; Jorge JH; Pavarina AC
    Lasers Med Sci; 2017 May; 32(4):815-826. PubMed ID: 28280998
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased adherence of fluconazole-resistant isolates of Candida species to explanted esophageal mucosa.
    Lyman CA; Garrett KF; Peter J; Gonzalez C; Walsh TJ
    Eur J Clin Microbiol Infect Dis; 1999 Mar; 18(3):213-6. PubMed ID: 10357058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of the in vitro activity of fluconazole against Candida albicans and dermatophytes.
    Wildfeuer A; Seidl HP
    Arzneimittelforschung; 1995 Jul; 45(7):819-21. PubMed ID: 8573230
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
    Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
    J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Candida albicans biofilm inhibition by synergistic action of terpenes and fluconazole.
    Pemmaraju SC; Pruthi PA; Prasad R; Pruthi V
    Indian J Exp Biol; 2013 Nov; 51(11):1032-7. PubMed ID: 24416942
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of human serum on antifungal pharmacodynamics with Candida albicans.
    Zhanel GG; Saunders DG; Hoban DJ; Karlowsky JA
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2018-22. PubMed ID: 11408217
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison between efficacy of allicin and fluconazole against Candida albicans in vitro and in a systemic candidiasis mouse model.
    Khodavandi A; Alizadeh F; Harmal NS; Sidik SM; Othman F; Sekawi Z; Jahromi MA; Ng KP; Chong PP
    FEMS Microbiol Lett; 2011 Feb; 315(2):87-93. PubMed ID: 21204918
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [In vitro activity of fluconazole against Candida albicans isolated from blood culture].
    Pemán J; Cantón E; Orero A; Ubeda P; Viudes A; Pastor A; Gobernado M
    Rev Esp Quimioter; 1998 Dec; 11(4):339-43. PubMed ID: 10336314
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activities of fluconazole (UK 49,858) and ketoconazole against ketoconazole-susceptible and -resistant Candida albicans.
    Hughes CE; Bennett RL; Tuna IC; Beggs WH
    Antimicrob Agents Chemother; 1988 Feb; 32(2):209-12. PubMed ID: 2834995
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.